Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Human hair follicles have a unique way of using energy and might use the Cori cycle; blocking CCR5 could help treat hair loss.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Scarred skin in lichen planopilaris loses immune cells due to a decrease in a specific protein in skin cells.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

CBD can either promote or inhibit hair growth depending on the concentration used.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Simvastatin reduces inflammation and promotes hair regrowth in alopecia areata.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

Immune cells affect hair growth and could lead to new hair loss treatments.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Hair loss treatment caused more hair loss in a man.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

CD2 might be a new treatment target for patchy alopecia areata.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.